This study suggests that SGLT-2i as glucose lowering treatment in patients with diabetes has a positive effect on Covid-19 outcomes, therefore can be considered as an antidiabetic drug of choice, especially during the Covid-19 pandemic (Diabetes Research and Clinical Practice) Identified proteins may represent viable intervention or pharmacological targets to prevent, reverse or slow type 2 diabetes progression, and further research is needed to pursue these targets (Diabetologia) These recommendations have been endorsed by the American Association of Clinical Endocrinologists, the American Diabetes Association, the Association of Diabetes Care and Education Specialists, DiabetesIndia, the European Association for the Study of Diabetes, the International Society for Pediatric and Adolescent Diabetes, the Japanese Diabetes Society, and the Juvenile Diabetes Research Foundation (The Lancet Diabetes & Endocrinology) Being diagnosed with diabetes in childhood or adolescence can interfere with the normative developmental changes and interact with psychological and social factors in youth and their families. Integrated, collaborative care is therefore necessary (Pediatric Diabetes) Development of HF in diabetes is a complex and multifactorial process that involves different mechanisms (Diabetes Care) Despite the introduction of multiple novel therapeutics over the past two decades, rates of control in type 2 diabetes (T2D) and its comorbidities remain suboptimal and may have even declined (Diabetic Care) A qualitative study of diabetes and diabetes care experiences of young women with type 2 diabetes during their reproductive years (Diabetic Medicine) The present analysis aimed at assessing the independent association of BMI versus surrogate measures of central adiposity (including both WHtR and ABSI) with death from any cause in the large cohort of well-characterized individuals with type 2 diabetes from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study, which allows accounting for several potential sources of bias (Cardiovascular Diabetology) An evidence based and quality assured programme that aims to support the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes and reduce their chances of deterioration or exacerbation (NHS England) 25(OH)D concentrations seem to be affected by disease progression and type 2 diabetes diagnosis (Acta Diabetologica)
|